UK to spend more on medicines for US tariff exemptionnews2025-12-01T16:28:20+00:00December 1st, 2025|Endpoints News|
Novartis plans to lay off 550 workers at Swiss factory news2025-11-25T14:18:48+00:00November 25th, 2025|Endpoints News|
AstraZeneca to onshore rare disease portfolio as part of its $50B pledge to the USnews2025-11-21T19:33:41+00:00November 21st, 2025|Endpoints News|
Pentagon-backed Lumen is ready to drastically slash antibody manufacturing costsnews2025-11-20T20:46:37+00:00November 20th, 2025|Endpoints News|
Novartis, Moderna detail manufacturing expansions in the US, among othersnews2025-11-20T17:56:16+00:00November 20th, 2025|Endpoints News|
FDA approves new indication and monthly dose of Regeneron’s Eylea HDnews2025-11-20T14:14:22+00:00November 20th, 2025|Endpoints News|
New report suggests America must wean off China APIsnews2025-11-18T20:37:33+00:00November 18th, 2025|Endpoints News|
New US trade deal caps Switzerland, Liechtenstein pharma tariffs at 15%news2025-11-17T19:14:06+00:00November 17th, 2025|Endpoints News|
Scholar Rock plans to launch spinal muscular atrophy drug next yearnews2025-11-17T17:48:23+00:00November 17th, 2025|Endpoints News|
Onshoring and data ‘fidelity’: What FDA wants from generic drug user fee talksnews2025-11-14T20:47:05+00:00November 14th, 2025|Endpoints News|
